Senior insider sale
Chief Medical Officer at AGIOS PHARMACEUTICALS, INC. — senior position signals high conviction
$970.2K
31.49K shares
What this filing means
GHEUENS SARAH plans to sell 31.49K shares of AGIOS PHARMACEUTICALS, INC. valued at approximately $970.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/21/2026ACC: 0001950047-26-010353
Officer· Chief Medical Officer
Since Sep 2021
31.49K
Shares to sell
$970.2K
Approx. market value
1.49K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
10/21/2026
1.49KTotal acquired1.49K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/21/2026 | Stock Option Exercise Cash | 1.49K | — |
| Total | 1.49K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
30K
Market value
$914.3K
8/4/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.49K
Market value
$55.9K
10/21/2026
Total
Units
31.49K
Value
$970.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/4/2026 | 30K | $914.3K | — | Completed |
| Planned — Approximate Date | ||||
10/21/2026 | 1.49K | $55.9K | NASDAQ | Planned |
| Total | 31.49K | $970.2K | ||